23255-32-5Relevant articles and documents
ADMINISTRATION OF A TLR2 AGONIST FOR THE TREATMENT OR PREVENTION OF A RESPIRATORY CONDITION ASSOCIATED WITH AN INFECTIOUS AGENT
-
Page/Page column 95; 96, (2019/07/13)
The present invention relates to methods of treating or preventing respiratory conditions. In particular, the methods relate to treatment of respiratory conditions associated with a virus, such as influenza. In particular, the present invention provides a method of treating or preventing a respiratory condition associated with an infectious agent in an individual, the method comprising administering a compound comprising a TLR2 agonist to the upper respiratory tract of the individual, thereby treating or preventing a respiratory condition associated with an infectious agent in the individual. The compound is not administered to the lower respiratory tract or to both the upper and lower respiratory tract (i.e. administered to the total respiratory tract).
Structure and synthesis of an immunoactive lipopeptide, WS1279, of microbial origin
Tsuda,Okada,Tanaka,Shigematsu,Hori,Goto,Hashimoto
, p. 607 - 611 (2007/10/02)
-
S-carboxymethylcysteine synthase from Escherichia coli
Kumagai,Suzuki,Shigematsu,Tochikura
, p. 2481 - 2487 (2007/10/02)
-